China YCT International Group Files Registration Statement on Form S-1 and Application for NASDAQ Capital Market Listing Life Science
Ironwood Pharmaceuticals Initiates Phase IIIb Study of Linaclotide in Adult Patients with Irritable Bowel Syndrome with Constipation (IBS-C) Life Science
Broadcom has a new strategy after failing to buy Qualcomm for $100 billion: Roll up a bunch of enterprise software companies Technology
OrigiMed Collaborates with Illumina to Further Develop and Promote its Advanced Clinical Molecular Tumor Applications Life Science